Skip to content
The wire
Wall Street
ASXASX 200 8,730 down -1.04%as at 20 Nov 2026, 5:53 am GMT+0800BHP Group (BHP) 51.40 AUD down -1.80%as at 20 Nov 2026, 1:54 pm GMT+0800Commonwealth Bank (CBA) 169.92 AUD down -1.00%as at 20 Nov 2026, 1:54 pm GMT+0800CommoditiesBrent Crude Oil (Brent Futures) 92.58 USD/bbl up +0.65%as at 21 Nov 2026, 6:40 am GMT+0800WTI Crude Oil (WTI Futures) 83.56 USD/bbl up +1.36%as at 21 Nov 2026, 6:40 am GMT+0800EuronextCAC 40 7,927.75 down -1.89%as at 21 Nov 2026, 6:40 am GMT+0800Euro StoxxEURO STOXX 50 5,936.85 down -2.90%as at 21 Nov 2026, 6:40 am GMT+0800FTSEFTSE 100 10,348.55 down -1.00%as at 21 Nov 2026, 6:40 am GMT+0800HKEXHANG SENG 22,410.80 down -1.89%as at 21 Nov 2026, 6:40 am GMT+0800NasdaqAlphabet (GOOGL) 265.29 USD down -2.70%as at 21 Nov 2026, 6:40 am GMT+0800Amazon (AMZN) 246.82 USD down -4.10%as at 21 Nov 2026, 6:40 am GMT+0800Apple (AAPL) 342.56 USD down -1.90%as at 21 Nov 2026, 6:40 am GMT+0800DOW JONES 48,147.33 down -1.93%as at 21 Nov 2026, 6:40 am GMT+0800Meta Platforms (META) 560.84 USD down -5.93%as at 21 Nov 2026, 6:40 am GMT+0800NASDAQ 22,617.73 down -5.28%as at 21 Nov 2026, 6:40 am GMT+0800S&P 500 6,910.39 down -3.70%as at 21 Nov 2026, 6:40 am GMT+0800Tesla (TSLA) 345.82 USD down -7.64%as at 21 Nov 2026, 6:40 am GMT+0800NSENIFTY 50 25,800.60 up +1.12%as at 21 Nov 2026, 6:40 am GMT+0800NYSEBerkshire Hathaway (BRK.B) 570.00 USD down -0.36%as at 21 Nov 2026, 6:40 am GMT+0800NZXNZX 50 14,107.41 down -0.98%as at 20 Nov 2026, 1:54 pm GMT+0800Russell 2000RUSSELL 2000 2,581.79 down -2.76%as at 21 Nov 2026, 6:40 am GMT+0800SSESHANGHAI COMPOSITE 3,533.79 down -1.22%as at 21 Nov 2026, 6:40 am GMT+0800TSENIKKEI 225 56,436.65 down -5.06%as at 21 Nov 2026, 6:40 am GMT+0800XetraDAX 40 24,782.95 down -2.67%as at 21 Nov 2026, 6:40 am GMT+0800CryptoBTC/USD 58,970.00 USD down -5.21%as at 21 Nov 2026, 6:40 am GMT+0800Ethereum (ETH/USD) 1,618.91 USD down -8.16%as at 21 Nov 2026, 6:40 am GMT+0800SOL/USD 68.960 USD down -5.75%as at 21 Nov 2026, 6:40 am GMT+0800XRP/USD 0.91172 USD down -5.28%as at 21 Nov 2026, 6:40 am GMT+0800ForexAUD/EUR 0.607100 EUR down -0.31%as at 20 Nov 2026, 1:54 pm GMT+0800AUD/GBP 0.508500 GBP up +0.02%as at 20 Nov 2026, 1:54 pm GMT+0800AUD/JPY 106.1100 JPY down -0.41%as at 20 Nov 2026, 1:54 pm GMT+0800AUD/NZD 1.212700 NZD down -0.18%as at 20 Nov 2026, 1:54 pm GMT+0800AUD/USD 0.666600 USD down -0.16%as at 20 Nov 2026, 1:54 pm GMT+0800EUR/GBP 0.837589 GBP up +0.33%as at 20 Nov 2026, 1:54 pm GMT+0800EUR/USD 1.098007 USD up +0.15%as at 20 Nov 2026, 1:54 pm GMT+0800GBP/USD 1.310914 USD down -0.18%as at 20 Nov 2026, 1:54 pm GMT+0800NZD/USD 0.549683 USD up +0.02%as at 20 Nov 2026, 1:54 pm GMT+0800USD/CAD 1.432343 CAD down -0.14%as at 20 Nov 2026, 1:54 pm GMT+0800USD/CHF 0.842034 CHF down -0.19%as at 20 Nov 2026, 1:54 pm GMT+0800USD/CNY 6.671617 CNY up +0.08%as at 20 Nov 2026, 1:54 pm GMT+0800USD/JPY 159.1809 JPY down -0.25%as at 20 Nov 2026, 1:54 pm GMT+0800
Rates
  • AURBA4.85%Next 8 Dec
  • USFed3.75-4.00%Next 10 Dec
  • UKBoE4.00%Next 17 Dec
  • EUECB2.50%Next 17 Dec
  • JPBoJ1.25%Next 18 Dec
  • CABoC2.50%Next 9 Dec
  • NZRBNZ2.75%Next 9 Dec
  • USUS CPI+0.4% m/mOct
  • USPayrolls+165,000 jobsOct 2026, seasonally adjusted monthly payroll change
  • USUS jobless4.1%Oct 2026, seasonally adjusted unemployment rate
  • USCore PCE3.1% y/ySep 2026, core PCE price index y/y
  • USUS GDP+3.4% annualisedQ3 2026, q/q seasonally adjusted annual rate
  • USUS retail+0.8% m/mSep 2026, m/m retail sales, seasonally adjusted
  • USISM mfg55.5Oct 2026, ISM manufacturing PMI index points
  • AUAU CPI4.3% y/ySep 2026, CPI y/y
  • AUAU jobless4.9%Oct 2026, seasonally adjusted unemployment
  • AUAU GDP+0.4% q/qQ2 2026, seasonally adjusted real GDP q/q
  • UKUK CPI3.6% y/yOct 2026, 12-month CPI
  • UKUK jobless4.7%Jun-Aug 2026, ILO unemployment
  • UKUK GDP+0.7% q/qQ3 2026, real GDP q/q
  • EUEZ CPI4.0% y/yOct 2026 euro-area HICP, flash estimate
  • CNChina GDP4.5% y/yQ3 2026, real GDP y/y
  • XAUGold4,052.40 USD/oz-1.49%
  • OILBrent99.69 USD/bbl+1.42%
  • OILWTI91.36 USD/bbl+0.11%
  • USUS 10Y4.837%-0.057 pts
  • VIXVIX28.18+69.66%
  • USDDXY101.768+0.21%
  • BTCBitcoin75,551.00 USD-6.09%
Saturday 21 November 2026A wider view Independent in spirit. Open by design.

The headline.
The whole story.

Live desk
On the agenda Kempsey arrow attackTakata airbag recallRussia-PolandData centre taxFuture citiesAI and accountability
BreakingRoundup settlement Business 3 min read

Up to US$165,000 each, paid over two decades: a US judge approves Bayer’s US$7.25 billion Roundup cancer deal, and Australia’s cases got nothing

A Missouri judge has approved Bayer's US$7.25 billion (about A$11 billion) settlement covering current and future claims that its Roundup weedkiller caused non-Hodgkin lymphoma. Average payments will range from about US$10,000 to US$165,000 and the money will be paid out over roughly two decades. Bayer still denies Roundup causes cancer, and the approval can be appealed.

Valcored News Network © Valcored News. All rights reserved.

Live updates

Times in GMT+0800
  1. 12.05pm AWSTLatest

    Bayer chief executive Bill Anderson calls the approval a decisive milestone. The company still denies Roundup causes cancer, and the ruling can be appealed.

  2. Saturday morning AWST

    St Louis Circuit Judge Timothy Boyer approves Bayer's US$7.25 billion Roundup class settlement, rejecting objections and finding no collusion.

This page checks for new updates automatically.

Three things to know

  1. St Louis Circuit Judge Timothy Boyer approved the nationwide class settlement on Friday US time (Saturday morning AWST), rejecting objections to it.
  2. It covers people already diagnosed with non-Hodgkin lymphoma after Roundup exposure, and people diagnosed within a 16-year window after final approval.
  3. In Australia, the Federal Court dismissed the lead Roundup class action in July 2024, and a second was discontinued in January 2025, both without compensation.

Bayer has cleared the biggest hurdle yet in a legal fight that has hung over it since 2018: a US judge has approved its US$7.25 billion (about A$11 billion) settlement of current and future claims that Roundup weedkiller caused cancer.

St Louis Circuit Judge Timothy Boyer approved the nationwide class settlement in a Missouri state court on Friday US time (Saturday morning AWST), rejecting a string of objections. He found no evidence of collusion, noting negotiations ran for more than 18 months, and called the deal “among the largest in the history of mass tort personal-injury class action settlements”.

Bayer chief executive Bill Anderson called the approval “a decisive milestone”. The company denies that Roundup or its active ingredient, glyphosate, causes cancer.

Who gets paid, and how much?

The settlement covers two groups. The first is people exposed to Roundup before 17 February 2026 who already have a non-Hodgkin lymphoma diagnosis. The second is people diagnosed with the blood cancer within 16 years of final approval.

Average payments will range from about US$10,000 (A$15,000) to US$165,000 (about A$250,000), depending on how much Roundup a person used, their age at diagnosis and how severe their illness is. Judge Boyer called the average payments fair and adequate.

Bayer will pay the money over about two decades in capped annual instalments, with US$3 billion committed over the first five years for those already diagnosed. US$600 million of the total is set aside for lawyers’ fees.

Why did Bayer settle now?

Because the courts had started to close doors on both sides. In June, the US Supreme Court ruled 7-2 that federal pesticide law blocks failure-to-warn claims in state courts, removing the main argument many plaintiffs had relied on. At the same time, Judge Boyer said there was a risk Bayer would have sought bankruptcy protection if the settlement had been rejected, which could have left claimants waiting years for less.

Bayer has faced about 200,000 Roundup claims since it bought Monsanto, Roundup’s maker, for US$63 billion in 2018. More than 30,000 cases sit in Missouri courts alone, and just over 200 plaintiffs already had trial dates.

What does it mean for Australians?

Nothing in cash. Australia’s Roundup cases ended without compensation: the Federal Court dismissed the McNickle class action in July 2024, finding the evidence did not establish that glyphosate causes non-Hodgkin lymphoma, and the second class action was discontinued in January 2025. Glyphosate remains registered for use in Australia and is one of the most widely used weedkillers on Australian farms.

In the US, glyphosate has already been removed from new versions of Roundup sold for home gardens.

Is it over?

Not quite. The approval can be appealed, and some plaintiffs’ lawyers oppose the deal.

VNN will update this story as more is confirmed.

How we got here

The key moments that brought this story into focus. Open any moment for detail.

  1. 2018Bayer buys Monsanto

    Bayer pays US$63 billion for Monsanto, Roundup's maker, inheriting thousands of cancer claims.

  2. July 2024Australian case dismissed

    The Federal Court dismisses the McNickle Roundup class action.

  3. January 2025Second Australian case ends

    Australia's other Roundup class action is discontinued without compensation.

  4. 17 February 2026Settlement proposed

    Bayer announces the US$7.25 billion class settlement for current and future claims.

  5. June 2026Supreme Court ruling

    The US Supreme Court rules 7-2 that federal law blocks failure-to-warn claims in state courts.

  6. 20 November 2026Settlement approved

    A Missouri judge approves the settlement.

What happens next

Objectors can appeal the approval. Once the settlement is final, claimants in the first group can start the payment process, with US$3 billion due over the first five years, while the 16-year window for new diagnoses begins. Bayer's shares next trade in Frankfurt on Monday 23 November, the first chance for investors to react.

Sources

  • VNN

VNN never names people who give us information in confidence. How we protect sources and tips.

The headline. The whole story.

Spotted something we should check? Tell the newsroom.

Comments

0 comments

Community rules

To read and join the conversation, please agree to our rules.

  1. Be respectful. No insults, name-calling, harassment, threats or hate.
  2. No links, web addresses or email addresses of any kind.
  3. No spam, advertising or self-promotion.
  4. One comment per story. You can reply to other people's comments, and to replies on yours.
  5. Stay on topic and keep personal information private.
  6. Comments that break these rules are removed, and repeat offenders are blocked.

Accessibility

Change how this website looks and behaves for you. Your choices are saved in this browser on this device only.

Text

Text size100%

Colour and links

Movement and focus

Read and find your way

Jump to a section of this page

    Your browser and device also have accessibility settings, such as zoom (Ctrl or ⌘ and +), a screen reader and reduced motion. This website works with them.

    Your privacy choices

    We use cookies and similar technologies to run this website. With your permission, we would also use them for advertising and embedded videos and social media posts. You can change your mind at any time with “Cookie settings” at the bottom of every page. Cookies policy.

    Cookie settings

    Choose what you allow. Storage the website needs to work is always on. You can come back here at any time from “Cookie settings” at the bottom of every page.

    • Strictly necessary

      Security, signing in, payments you start, protection against ad fraud and remembering your cookie choice.

      Always on
      What is stored (10)
      • vnn_consent VNN (this website) · Cookie · 12 months
        Remembers your cookie choices so we do not ask on every page.
      • wordpress_logged_in_*, wordpress_sec_* WordPress (this website) · Cookie · Until you sign out, up to 14 days
        Keeps you signed in, if you have an account (VNN staff, subscribers and buyers).
      • wordpress_test_cookie WordPress (this website) · Cookie · Until you close the browser
        Checks your browser accepts cookies when you sign in.
      • wp-settings-*, wp-settings-time-* WordPress (this website) · Cookie · 1 year
        Remembers dashboard layout for VNN staff. Not set for readers.
      • vcn_co VNN (this website) · Cookie · 1 day
        Links a payment to the browser that made it, so a new reader is signed in straight away after paying.
      • vnn_rules VNN (this website) · Cookie · 1 year
        Remembers that you agreed to the community rules before commenting.
      • vnn.rules VNN (this website) · Local storage · Until you clear your browser data
        The same agreement, kept in your browser as a back-up.
      • vnn.adshield.block, vnn.adshield.clicks VNN (this website) · Local storage · Up to 24 hours
        Protects our advertisers from invalid clicks (ad fraud) by pausing ads after repeated clicks.
      • vnn.adshield.ok VNN (this website) · Session storage · Until you close the tab
        Avoids re-checking the click protection on every page.
      • Payment security cookies Our card payment processor · Cookie · Up to 1 year
        Set only on the payment page and the billing part of your account page, to protect card payments from fraud.
    • Your settings on this device

      Saved stories, followed topics and other settings you choose. Kept in your browser only.

      Always on
      What is stored (7)
      • vcn.saved-stories.v1 VNN (this website) · Local storage · Until you remove them
        The stories you save with the bookmark button.
      • vcn.followed-topics.v1 VNN (this website) · Local storage · Until you remove them
        The topics you choose to follow.
      • vnn.alert.dismissed VNN (this website) · Session storage · Until you close the tab
        Remembers that you closed the breaking-news bar.
      • vnn.access VNN (this website) · Local storage · Until you reset them
        Your accessibility settings, such as text size and contrast.
      • vnn.support VNN (this website) · Local storage · Until you clear your browser data
        Remembers when you closed the “Support VNN” panel or gave, so it does not keep appearing.
      • comment_author_*, comment_author_email_* WordPress (this website) · Cookie · About 1 year
        Fills in your name and email on the comment form, only if you tick “Save my name”.
      • vnn-app-* VNN (this website) · Cache storage (service worker) · Until the app updates or you clear site data
        The web app’s icons and offline page, so it opens quickly and can tell you when you are offline.
    • Advertising

      Lets our advertising partner show ads based on your interests and measure them. If you say no, you may still see ads, but they are not personalised.

      What is stored (1)
      • __gads, __gpi, __eoi and Google ad cookies (e.g. IDE on doubleclick.net) Google AdSense · Cookie · Up to 13 months (set by Google)
        Shows ads, limits how often you see the same ad, prevents fraud and measures results. Ads are personalised only if you accept advertising.
    • Embedded videos and posts

      Loads videos, social media posts and other content hosted by other companies, such as YouTube or X. They may set their own cookies. If you say no, each one waits until you choose to load it.

      What is stored (1)
      • Set by the provider YouTube, Vimeo, X (Twitter), Instagram, TikTok, Facebook, Spotify and other embedded services · Cookie · Set by the provider
        Plays videos and shows posts inside our stories. Nothing loads until you choose to load it or allow embedded content.

    Full details: Cookies policy.

    VNNVALCORED NEWS NETWORK

    Install the VNN web app

    Choose your device to see how to add VNN to your home screen.

      What is the VNN web app?

      It is this website, saved to your home screen so it opens like an app: full screen, one tap away, straight to the front page. It is free, there is no app store download, it uses almost no storage and it updates itself. To remove it, press and hold the VNN icon and choose Remove. What the web app stores on your device